CPC A61K 35/17 (2013.01) [A61P 35/00 (2018.01); C12N 5/0646 (2013.01)] | 14 Claims |
1. A method for producing an NKT cell ligand-pulsed human CD14 positive CD1d positive cell, comprising a step of culturing an isolated CD14 positive CD1d positive cell in a serum free medium containing an NKT cell ligand and GM-CSF at a concentration of 33.3-666.7 ng/mL,
wherein the NKT cell ligand is a compound represented by the formula
or a salt thereof,
a compound represented by the formula
or a salt thereof,
a compound represented by the formula
or a salt thereof, or
α GalCer.
|